Skip to content
healthcare.dev
Get a free key

Hydralazine Hydrochloride

NDC 50111-397, Hydralazine Hydrochloride, tablet, from Teva Pharmaceuticals USA, Inc..

Product NDC
50111-397
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA089098
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50111-397 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
50111-397-0150111039701100 TABLET in 1 BOTTLE (50111-397-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ddbbdb09-3202-42d7-bbb0-08331dde2f54

  • NADAC price for package 50111039701

    GET /v1/drugs/nadac/50111039701

Use it

Look up 50111-397 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50111-397 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50111-397. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.